[1]
“Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 559–571, Sep. 2022, doi: 10.47750/pnr.2022.13.03.085.